Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (29)
  • PD-1/PD-L1
    (18)
  • Autophagy
    (7)
  • JAK
    (6)
  • Akt
    (5)
  • COX
    (5)
  • Calcium Channel
    (5)
  • HDAC
    (5)
  • Immunology/Inflammation related
    (5)
  • Others
    (272)
Filter
Search Result
Results for "

t cell

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    558
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    4
    TargetMol | Compound_Libraries
  • Peptide Products
    98
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    92
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    5
    TargetMol | Dye_Reagents
  • PROTAC Products
    14
    TargetMol | PROTAC
  • Natural Products
    49
    TargetMol | Natural_Products
  • Reagent Kits
    9
    TargetMol | Reagent_Kits
  • Recombinant Protein
    499
    TargetMol | Recombinant_Protein
  • Isotope Products
    9
    TargetMol | Isotope_Products
  • Antibody Products
    40
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
Dacarbazine
Imidazole Carboxamide, DTIC-Dome
T11204342-03-4
Dacarbazine (DTIC-Dome) is an antineoplastic agent. It has significant activity against melanomas.
  • Inquiry Price
Size
QTY
Mast cell degranulating peptide (28-49)
TP156865636-54-6
Mast cell degranulating peptide (28-49) is a bee venom depolarizer that enhances cGMP levels in cerebellum tablets of mice.
  • Inquiry Price
Size
QTY
Mast Cell Degranulating Peptide HR-2 acetate
Mast Cell Degranulating Peptide HR-2 acetate(80388-04-1 free base)
TP1497L
Mast Cell Degranulating Peptide HR-2 acetate from giant hornet Vespa orientalis that has biological effects similar to mast cell degranulating peptide from bee venom.
  • Inquiry Price
Size
QTY
Mast Cell Degranulating Peptide HR-2
TP149780388-04-1
Peptide from giant hornet Vespa orientalis that has biological effects similar to mast cell degranulating peptide from bee venom.
  • Inquiry Price
Size
QTY
Cisplatin-resistant cells-IN-1
T82715
Cisplatin-resistant cells-IN-1 (Compound 8) exhibits high cytotoxicity against Cisplatin-resistant cells and effectively diminishes metabolic activity at low nanomolar concentrations, with an IC50 ranging from 0.14 to 1.79 μM in various resistant cell lines, including A549 A549-R, K562 K562-R, and MCF-7 MCF-7TamR [1].
  • Inquiry Price
Size
QTY
BAY 11-7082
BAY 11-7821
T190219542-67-7
BAY 11-7082 (BAY 11-7821) is an NF-κB inhibitor that suppresses TNFα-induced IκBα phosphorylation (IC50=10 μM) and also inhibits the ubiquitin-specific proteases USP7 and USP21 (IC50=0.19 0.96 μM).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
RO2959 Hydrochloride
RO2959 HCl
T88671219927-22-6
RO2959 Hydrochloride (RO2959 HCl) is a potent and selective inhibitor of CRAC channel(IC50: 402 nM). It is also a potent inhibitor of human IL-2.
  • Inquiry Price
Size
QTY
Dazostinag disodium
T724822553413-93-5In house
Dazostinag disodium (TAK-676) is a synthetic novel interferon gene (STING) agonist that triggers STING signaling pathway activation and type I interferon activation. Dazostinag disodium (TAK-676) is also a highly effective immune system modulator with complete resolution and lasting memory of T cell immunity and the ability to promote lasting interferon-dependent anti-tumor immune responses.
  • Inquiry Price
10-14 weeks
Size
QTY
TargetMol | Inhibitor Hot
osunprotafib
Osunprotafib, AC484, AC 484, ABBV-CLS-484
T616992489404-97-7In house
Osunprotafib (ABBV-CLS-484) is a potent, orally bioavailable PTP1B PTPN2 inhibitor in clinical trials for solid tumors. [1] Osunprotafib (ABBV-CLS-484) stimulates the tumor microenvironment and promotes natural killer cell and CD8 T cell function and enhances T cell anti-tumor immunity by enhancing JAK-STAT signaling and reducing T cell dysfunction. [2]
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Hot
romidepsin
NSC 630176, FR 901228, FK 228, Depsipeptide
T6006128517-07-7
Romidepsin (FR 901228) is an HDAC inhibitor that inhibits HDAC1 2 4 6 (IC50=36 47 510 1400 nM). Romidepsin has antitumor activity and can be used for the treatment of peripheral T-cell lymphoma and cutaneous T-cell lymphoma.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
gnf4877
T114472041073-22-5In house
GNF4877 is a potent inhibitor of DYRK1A and GSK3β (IC50s: 6 nM and 16 nM, respectively), resulting in the blockade of nuclear export of nuclear factor of activated T-cells (NFATc) and increased β-cell proliferation.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Cycloheximide
Naramycin A, CHX, Actidione
T122566-81-9
Cycloheximide (Naramycin A) is a natural product that reversibly inhibits translation elongation, is an antimitotic compound, and is an inhibitor of DNA and protein synthesis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
BAY-218
AHR antagonist 1
T56222162982-11-6
Bindarit (AF2838)is an aryl hydrocarbon receptor (AHR) antagonist with IC50 of 39.9 nM in the human glioblastoma U87 cell line. BAY-218 inhibition of AhR stimulates pro-inflammatory monocyte and T cell responses in vitro and drives anti-tumor immune responses, leading to reduced tumor growth in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
SIRT6-IN-5
SIRT6 inhibitor5, SIRT6 IN 5, SIRT6 inhibitor-5, SIRT6 inhibitor 5
T24793891002-11-2In house
SIRT6-IN-5(SIRT6 inhibitor 5) is a potent and selective SIRT6 inhibitor with an IC50 value of 34 μM.SIRT6-IN-5 is immunosuppressive and chemo-sensitizing, increases H3K9 acetylation and glucose uptake in cultured cells, and reduces T-cell proliferation.
  • Inquiry Price
6-8 weeks
Size
QTY
JAK3i
JAK-3i, JAK 3i
T276501918238-72-8In house
JAK3i is a selective covalent inhibitor of JAK3 kinase. JAK3i reveals two distinct temporal waves of STAT5 phosphorylation and more potently targets the second wave, which is required for cell cycle progression and T cell proliferation.
  • Inquiry Price
6-8weeks
Size
QTY
5-A-RU
5-Amino-6-(D-ribitylamino)uracil
T1016517014-74-3In house
5-A-RU (5-Amino-6-(D-ribitylamino)uracil) is an early intermediate in riboflavin biosynthesis and is found in a variety of bacteria and yeast as well as plants. 5-A-RU is also a mucosal-associated invariant T (MAIT) cell activator that forms potent MAIT-activating antigens through non-enzymatic reactions with small molecules from other metabolic pathways.
  • Inquiry Price
Inquiry
Size
QTY
(Rac)-SHIN2
T729842204289-53-0In house
(Rac)-SHIN2, a serine hydroxymethyltransferase (SHMT) inhibitor, enhances NOTCH1-driven in vivo survival of primary T-ALL in mice and is useful for studying T-cell acute lymphoblastic leukemia (T-ALL).
  • Inquiry Price
6-8 weeks
Size
QTY
PF-04447943
PF 04447943, Edelinontrine, PF04447943
T164781082744-20-4In house
PF-04447943 (Edelinontrine) is a potent and selective phosphodiesterase 9A inhibitor with an IC50 of 12 nM, which is 78-fold more selective than that used for other PDE family members (IC50>1000 nM).PF-04447943 exhibits anti-inflammatory activity, attenuates inflammatory responses by inhibiting oxidative stress, inflammation, and modulating T-cell polarization, and may be useful for research on sickle cell anemia.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
jak3-in-11
T98112412734-00-8In house
JAK3-IN-11 (Compound 12) exhibits potent, noncytotoxic, irreversible, orally active JAK3 inhibitory activity (IC50 = 1.7 nM) with an excellent selectivity profile (>588-fold compared to other JAK isoforms), covalently binds to the ATP-binding pocket in JAK3. JAK3-IN-11 strongly inhibits JAK3-dependent signaling and T-cell proliferation which is a promising tool for studying autoimmune diseases [1].
  • Inquiry Price
10-14 weeks
Size
QTY
TP-16
T625252332972-26-4In house
TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.
  • Inquiry Price
7-10 days
Size
QTY
GNE-1858
T114382680616-96-8In house
GNE-1858 is an ATP-competitive hematopoietic progenitor kinase-1 (HPK1) inhibitor (IC50s of 1.9 nM, 1.9 nM, and 4.5 nM for wild-type and the active mimetic mutants HPK1-TSEE and HPK1-SA).
  • Inquiry Price
6-8 weeks
Size
QTY
Anisperimus
LF15-0195, LF-15-0195, LF-150195, LF 15-0195, LF 150195
T30077170368-04-4In house
Anisperimus (LF 15-0195) is an immunosuppressant that enhances activation-induced T-cell death by promoting caspase-8 and caspase-10 activation at the DISC level, and prevents CNS autoimmunity by promoting the development of Foxp3-expressing regulatory CD4 T cells.
  • Inquiry Price
6-8 weeks
Size
QTY
KRM-III
T3588579220-94-3In house
KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate fosfomycin ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
α-(difluoromethyl)-DL-Arginine
α-(difluoromethyl)-DL-Arginine, RMI 71897, DFMA
T3544969955-43-7In house
α-(difluoromethyl)-DL-Arginine (RMI 71897) is an enzyma-activated, irreversible inhibitor of arginine decarboxylase for E. coli (Ki = 800 μM), Pseudomonas aeruginosa, and Klebsiella pneumoniae. At 0.01 mM, it has been shown to prevent osmotic stress-induced increases in arginine decarboxylase activity and putrescine synthesis in oat leaf cells. When combined with a variety of polyamine analogues, α-(difluoromethyl)-DL-Arginine inhibited the growth of Trypanosoma Crui in mammalian host cells at a minimum concentration of 10 mM and prevented the growth of Trypanosoma Crui in T-cell receptor alpha-deficient mouse models.
  • Inquiry Price
8-10 weeks
Size
QTY